Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fibrinogen Early In Severe Trauma StudY II

NCT05449834 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT05449834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05449834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fibrinogen Early In Severe Trauma StudY II
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Phase 3
Overall status
Completed
Start date
November 21, 2022
Completion date
July 15, 2026
Enrollment
900 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

coagulopathy, haemorrhagic shock, trauma